Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study

FP treatment, which combines 5-fluorouracil (5-FU) and cisplatin (CDDP) chemotherapy, is widely used for treatment of advanced head and neck cancer (HNC). It has been suggested that these drugs cause immunomodulation in the cancer microenvironment, for example, downregulation of immunosuppressive ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishio-Nagai, Mayako, Suzuki, Susumu, Yoshikawa, Kazuhiro, Ueda, Ryuzo, Kazaoka, Yoshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643067/
https://www.ncbi.nlm.nih.gov/pubmed/29048671
http://dx.doi.org/10.3892/ijo.2017.4142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643067/
https://www.ncbi.nlm.nih.gov/pubmed/29048671
http://dx.doi.org/10.3892/ijo.2017.4142

Ejemplares similares